Posted on 12/14/20
Curis Closes of Public Offering of Common Stock with $169.6 Million in Gross Proceeds
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the closing of its underwritten . . .
Posted on 12/14/20
AdaptHealth Proposed Offering of $500 Million Senior Notes
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .
Posted on 12/14/20
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 12/14/20
Virginia Leads Nation in COVID-19 App Use
Amid grim headlines related to the coronavirus, Virginia has one piece of bright news — the commonwealth leads the nation in the percentage of citizens who . . .
Posted on 12/14/20
TG Therapeutics Proposed Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, . . .
Posted on 12/14/20
Why Lexicon Pharmaceuticals Flopped on Friday
What happenedLexicon Pharmaceuticals (NASDAQ:LXRX) ended Friday 6% lower than the previous close. A fall seemed inevitable, as the company announced a rather dilutive new secondary common . . .
Posted on 12/14/20
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Big problems tend to attract big problem solvers. So when a global pandemic first threatened the world earlier this year, it wasn't surprising that the two . . .
Posted on 12/14/20
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Reviewers at the Food and Drug Administration (FDA) are working overtime these days. On Friday, the agency issued a late-evening emergency use authorization for Pfizer (NYSE:PFE) . . .
Posted on 12/14/20
Novavax Stock: Buy at the High?
Of all the rags to riches stories that the pandemic has fueled for drugmakers, few are as incredible as Novavax (NASDAQ:NVAX). Shares are up about 2,500% . . .
Posted on 12/14/20
Should Investors Buy Inovio for Its Coronavirus Vaccine?
Inovio Pharmaceuticals (NASDAQ:INO) is trailing the leaders with its coronavirus vaccine, INO-4800. Some of the slow start is tied to manufacturing issues for one of the . . .
Posted on 12/14/20
The Next Major Pharmaceutical Acquisition Is Here
Summary AstraZeneca has announced its acquiring Alexion at a fairly substantial 45% premium. It's a mixed stock - cash offer.The synergies will cover most of the . . .
Posted on 12/14/20
U.S. Government Orders 100 Million More Doses of Moderna's Coronavirus Vaccine
The pandemic-ravaged U.S. is set to receive an additional 100 million doses of Moderna's (NASDAQ:MRNA) coronavirus vaccine, the company announced after market hours on Friday. The . . .
Posted on 12/14/20
Moderna Investors, Meet Mr. Market
If you had an eccentric friend with a reputation for impulsiveness and hyperbole, you'd definitely think twice before agreeing with their appraisal of their latest obsession, . . .
Posted on 12/14/20
Why Berkshire Hathaway Is a Retiree's Dream Stock
There's no denying that the past couple of years have been relatively disappointing ones for Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) shareholders. Stock in the Warren Buffett-led multinational . . .
Posted on 12/14/20
Where Will Moderna Be in 5 Years?
Can you name a company that's developing drugs for rare inherited illnesses, blocked arteries, and vaccines for infectious diseases you've never heard of? Since you clicked . . .
Posted on 12/14/20
Why Did This Big Investor Sell Its Moderna Stock?
Merck (NYSE:MRK) had been an investor in Moderna(NASDAQ:MRNA) since before the biotech had its initial public offering. But the big pharma recently disclosed that it sold . . .
Posted on 12/14/20
How Many COVID Vaccine Doses Will Pfizer and Moderna Distribute by Year-End?
Good news could be right around the corner. Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) hope to soon win FDA emergency use authorizations (EUA) for their respective COVID-19 . . .
Posted on 12/14/20
Buy, Sell, or Hold Moderna Stock at an All-Time High?
Now that Pfizer's (NYSE:PFE) COVID vaccine has received emergency use authorization in the U.K., Canada, and the U.S., all eyes are on Moderna's (NASDAQ:MRNA) candidate to . . .
Posted on 12/13/20
Syndax Closes Public Offering
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the closing of its previously announced underwritten public . . .
Posted on 12/13/20
HOOKIPA Pharma Closes Public Offering of $80.9M of Common Stock
NEW YORK and VIENNA, Austria, Dec. 11, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on . . .
Posted on 12/11/20
CEL-SCI Closes of Its $14.65 Million Bought Deal
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company,announced the closing of the offering of 1,000,000 shares of its common stock at . . .
Posted on 12/11/20
MetLife Authorized $3 Billion Share Repurchase
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its . . .
Posted on 12/11/20
MetLife to Sell Auto & Home Business to Zurich Insurance Group Subsidiary Farmers Group for $3.94 Billion
MetLife, Inc. (NYSE: MET) today announced that it has signed a definitive agreement to sell Metropolitan Property and Casualty Insurance Company
Posted on 12/11/20
Forma Therapeutics Prices of Public Offering
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the pricing of an underwritten . . .
Posted on 12/11/20
Akari Therapeutics Reports Third Quarter 2020 Financial Results
NEW YORK and LONDON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan . . .

